LifeStance Health (LFST) Gross Margin (2020 - 2024)

LifeStance Health has disclosed Gross Margin across 5 years of filings, most recently posting 32.12% for Q3 2024.

• In Q3 2024, Gross Margin rose 313.0% year-over-year to 32.12%; the TTM figure through Sep 2024 stood at 31.2% (up 317.0% YoY), while the FY2023 annual figure was 28.62%, up 104.0% from the prior year.
• Gross Margin advanced to 32.12% in Q3 2024, from 31.31% in the prior quarter.
• Over the last five years, Gross Margin for LFST reached as high as 32.49% in Q3 2020 and fell as low as 26.69% in Q1 2022.
• The 5-year median for Gross Margin is 29.69% (2023), against an average of 29.67%.
• Annual changes were most pronounced in 2022 — Gross Margin tumbled 405 bps — and 2024, when it jumped 397 bps.
• A 5-year view of Gross Margin shows it stood at 32.49% in 2020, then retreated by 12 bps to 28.55% in 2021, then fell by 4 bps to 27.33% in 2022, then gained by 9 bps to 29.69% in 2023, then gained by 8 bps to 32.12% in 2024.
• According to Business Quant data, Gross Margin over the past three periods registered 32.12%, 31.31%, and 31.53% for Q3 2024, Q2 2024, and Q1 2024 respectively.